Cargando…

Interactions of physical activity, muscular fitness, adiposity, and genetic risk for NAFLD

Genetic predisposition and unhealthy lifestyle are risk factors for nonalcoholic fatty liver disease (NAFLD). We investigated whether the genetic risk of NAFLD is modified by physical activity, muscular fitness, and/or adiposity. In up to 242,524 UK Biobank participants without excessive alcohol int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schnurr, Theresia M., Katz, Sophia Figueroa, Justesen, Johanne M., O’Sullivan, Jack W., Saliba‐Gustafsson, Peter, Assimes, Themistocles L., Carcamo‐Orive, Ivan, Ahmed, Aijaz, Ashley, Euan A., Hansen, Torben, Knowles, Joshua W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234625/ https://www.ncbi.nlm.nih.gov/pubmed/35293152 http://dx.doi.org/10.1002/hep4.1932

Ejemplares similares

Integration of genetic colocalizations with physiological and pharmacological perturbations identifies cardiometabolic disease genes
por: Gloudemans, Michael J., et al.
Publicado: (2022)

Health disparities in cardiometabolic risk among Black and Hispanic youth in the United States
por: Katz, Sophia Figueroa, et al.
Publicado: (2021)

Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example
por: Goldstein, Benjamin A., et al.
Publicado: (2014)

Corrigendum: Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example
por: Goldstein, Benjamin A., et al.
Publicado: (2015)

The Role of Vitamin E in the Treatment of NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2018)

Biological Insights Into Muscular Strength: Genetic Findings in the UK Biobank
por: Tikkanen, Emmi, et al.
Publicado: (2018)

Large‐Scale Plasma Protein Profiling of Incident Myocardial Infarction, Ischemic Stroke, and Heart Failure
por: Lind, Lars, et al.
Publicado: (2021)

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD
por: Cholankeril, Rosann, et al.
Publicado: (2018)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
por: Iqbal, Umair, et al.
Publicado: (2018)

When to Initiate Weight Loss Medications in the NAFLD Population
por: Yoo, Eric R., et al.
Publicado: (2018)

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2019)

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2018)

Impact of a Genetic Risk Score for Coronary Artery Disease on Reducing Cardiovascular Risk: A Pilot Randomized Controlled Study
por: Knowles, Joshua W., et al.
Publicado: (2017)

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD
por: Dibba, Pratima, et al.
Publicado: (2018)

Higher Overall Intakes Are the Defining Feature of Dietary Intakes in NAFLD and Compared to the General Population
por: Properzi, Catherine, et al.
Publicado: (2023)

Smoking during pregnancy is associated with child overweight independent of maternal pre-pregnancy BMI and genetic predisposition to adiposity
por: Schnurr, Theresia M., et al.
Publicado: (2022)

Plasma proteomic signatures of a direct measure of insulin sensitivity in two population cohorts
por: Zanetti, Daniela, et al.
Publicado: (2023)

NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2020)

Editorial: The heart of NAFLD
por: Chew, Nicholas W. S., et al.
Publicado: (2023)

The influence of insulin-related genetic variants on fetal growth, fetal blood flow, and placental weight in a prospective pregnancy cohort
por: Reim, Pauline K., et al.
Publicado: (2023)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

Randomised Double-Blind Placebo-Controlled Trial of Inulin with Metronidazole in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Chong, Clara Yieh Lin, et al.
Publicado: (2020)

Insulin Resistance and Gender Define a Cell Autonomous Supernetworkof Protein Phosphorylation
por: Haider, Nida, et al.
Publicado: (2021)

Effects of Aqua Aerobic Therapy Exercise for Older Adults on Muscular Strength, Agility and Balance to Prevent Falling during Gait
por: Kim, Suk Bum, et al.
Publicado: (2013)

NAFLD in the Elderly
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Associations between a Genetic Risk Score for Clinical CAD and Early Stage Lesions in the Coronary Artery and the Aorta
por: Salfati, Elias L., et al.
Publicado: (2016)

Alcohol use and cardiometabolic risk in the UK Biobank: A Mendelian randomization study
por: Lankester, Joanna, et al.
Publicado: (2021)

Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease
por: Miao, Zong, et al.
Publicado: (2021)

Cardiovascular disease: The rise of the genetic risk score
por: Knowles, Joshua W., et al.
Publicado: (2018)

NAFLD and Infection, a Nuanced Relationship
por: Adenote, Abimbola, et al.
Publicado: (2021)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021)

S06-4 Exploring correlates of adolescent boys' muscular fitness: a mixed-methods formative study
por: Fairclough, Stuart J, et al.
Publicado: (2022)

Do genetic risk scores for childhood adiposity operate independent of BMI of their mothers?
por: Huang, Lam O., et al.
Publicado: (2021)

Current Management of NAFLD
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2016)

Practice Guidelines on NAFLD
por: Palmer, Melissa
Publicado: (2013)

NAFLD or comorbidities, that is the question
por: Ponziani, Francesca Romana, et al.
Publicado: (2020)

NAFLD and cardiovascular disease
por: Martins, Elisabete, et al.
Publicado: (2018)

Natural History of NAFLD
por: Pais, Raluca, et al.
Publicado: (2021)

New targets for NAFLD
por: Parlati, Lucia, et al.
Publicado: (2021)

Recent Developments in NAFLD
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ocrp57naneboii1e0ol87r9apt